Cycling has a longstanding and uneasy relationship with body image and weight, forged by a culture that's trickled down from the pro ranks, where every kilogram matters and diet is continuously under the microscope
If you're experiencing persistent GI reactions beyond the first month, consult your prescribing physician about dose adjustment, injection timing relative to meals, or transitioning to oral supplementation
LDN may emerge as the first of many glial cell modulators that could be used to treat chronic conditions, with more specifically targeted medications developed in the future
This target supports metabolic health, increases satiety duration, and works synergistically with semaglutide's appetite suppression
It has been established through clinical trials that GLP-1 receptor agonists (liraglutide and semaglutide) have proven to be consistently useful in lowering body weight, enhancing glycaemic control, and reducing cardiovascular risk [7,8,9].Nevertheless, since GLP-1 receptor agonists have the capability to work on several central nervous pathways, including the one controlling appetite, reward circuits, and the pancreatic-enteric-brain axis, the potential psychological impact of such agonists has increased with time [10,11,12]
If your genetic profile indicates heightened sensitivity to GLP-1 signaling, you and your PlexusDx provider can plan a slower dose escalation or explore alternatives like the Microdose GLP-1 Protocol ($129/mo) to minimize adjustment reactions while achieving results
